Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/134740
Título: Executive summary of outpatient parenteral antimicrobial therapy: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases and the Spanish Domiciliary Hospitalisation Society
Otros títulos: Resumen ejecutivo del tratamiento antimicrobiano domiciliario endovenoso: guía de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica y la Sociedad Española de Hospitalización a Domicilio
Autores/as: López Cortés, L. E.
Mujal Martínez, A
Fernández Martínez de Mandojana, M
Martín, N.
Gil Bermejo, M
Solà Aznar, J
Villegas Bruguera, E
Peláez Cantero, M. J
Retamar Gentil, P.
Delgado Vicente, M
González-Ramallo, V. J.
Ponce González, Miguel Angel 
Mirón Rubio, M.
Gómez Rodríguez de Mendarozqueta, M. M.
Goenaga Sánchez, M. A.
Sanroma Mendizábal, P.
Delgado Mejía, E.
Pajarón Guerrero, M.
Clasificación UNESCO: 32 Ciencias médicas
320505 Enfermedades infecciosas
320103 Microbiología clínica
Palabras clave: Home
Intravenous therapy
Outpatient parenteral antimicrobial therapy
Fecha de publicación: 2018
Publicación seriada: Enfermedades Infecciosas y Microbiologia Clinica 
Resumen: Outpatient parenteral antimicrobial therapy (OPAT) programmes make it possible to start or complete intravenous antimicrobial therapy for practically any type of infection at home, provided that patient selection is appropriate for the type of OPAT programme available. Although the clinical management of infections in the home setting is comparable in many respects to that offered in conventional hospitalization (selection of antibiotics, duration of treatment, etc.), there are many aspects that are specific to this care modality. It is essential to be aware of them so that OPAT continues to be as safe and effective as inpatient care. The objective of this clinical guideline is therefore to provide evidence- and expert-based recommendations with a view to standardizing clinical practice in this care modality and contribute to a progressive increase in the number of patients who can be cared for and receive intravenous therapy in their own homes.
URI: http://hdl.handle.net/10553/134740
ISSN: 0213-005X
DOI: 10.1016/j.eimc.2018.03.012
Fuente: Enfermedades Infecciosas y Microbiologia Clinica [ISSN 0213-005x], v. 37(6), p.405-409 (Mayo 2018)
Colección:Artículos
Vista completa

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.